Page last updated: 2024-09-05

7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid and linoleic acid

7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid has been researched along with linoleic acid in 1 studies

Compound Research Comparison

Studies
(7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid)
Trials
(7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid)
Recent Studies (post-2010)
(7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid)
Studies
(linoleic acid)
Trials
(linoleic acid)
Recent Studies (post-2010) (linoleic acid)
3915146,8783142,036

Protein Interaction Comparison

ProteinTaxonomy7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid (IC50)linoleic acid (IC50)
Fatty acid-binding protein, heartHomo sapiens (human)1
Seed linoleate 13S-lipoxygenase-1Glycine max (soybean)1
Fatty acid-binding protein, adipocyteHomo sapiens (human)1
Aldo-keto reductase family 1 member C3Homo sapiens (human)0.69

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, RF; Laposata, M; O'Connor, MG; Seegmiller, A; Thomsen, K1

Trials

1 trial(s) available for 7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid and linoleic acid

ArticleYear
Elevated prostaglandin E metabolites and abnormal plasma fatty acids at baseline in pediatric cystic fibrosis patients: a pilot study.
    Prostaglandins, leukotrienes, and essential fatty acids, 2016, Volume: 113

    Topics: Adolescent; Arachidonic Acid; Child; Cross-Over Studies; Cystic Fibrosis; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Fatty Acids; Female; Humans; Linoleic Acid; Male; Pilot Projects; Prospective Studies; Prostaglandins; Treatment Outcome

2016